As the ranking member of the House Intelligence Committee, Devin Nunes has recently been in the spotlight for his pro-Trump support during recent impeachment inquiry hearings. But like all members of Congress, he has an election coming up in 2020 and his Democrat challenger says his campaign has seen an outpouring of support since the hearings began.
"We've received over $300,000 in contributions since the beginning of this impeachment hearing from over 10,000 individual contributions," said Phil Arballo, who is trying to win the seat for California's 22nd District — a seat which Nunes has held since 2003.
Arballo, a Mexican-American businessman, entered the Democratic primary for the seat in June but said his campaign has seen a "groundswell of support" since attention shifted to Nunes during the hearings last week.
"As a constituent of his, and I can tell you from talking to a lot of people every day here on the ground, it's embarrassing, that he's our representative, here. He does not represent us here," Arballo said of the Central Valley.
Nunes defeated his Democratic challenger in 2018, but Arballo thinks the tide will turn in 2020.
"It's a very winnable seat," he said. "Everything is trending in the right direction for our race next year."
Nunes is not the only Republican whose role in the hearings may be helping Democratic challengers. Rep. Elise Stefanik of New York's 21st Congressional District played a prominent role in the hearings. Her 2020 challenger Tedra Cobb, who unsuccessfully challenged Stefanik in 2018, announced her campaign raised $1 million the weekend after the impeachment hearings.
President Joe Biden says the U.S. expects to take delivery of enough coronavirus vaccines for all adult Americans by the end of May, two months earlier than anticipated.
State Representative Marcus C. Evans, Jr. from Chicago filed amendments to an Illinois bill that would further ban games considered to be too violent from reaching the hands of minors.
Texas is lifting a COVID-19 mask mandate that was imposed last summer but has only been lightly enforced. Republican Gov. Greg Abbott’s announcement Tuesday makes Texas the largest state to do away with a face covering order.
Drugmaker Merck & Co. will help produce rival Johnson & Johnson’s newly approved coronavirus vaccine in an effort to expand supply more quickly.
Calls for New York Gov. Andrew Cuomo to resign are intensifying now that a third woman has accused him of offensive behavior.
The pill comprises 40% of the profits in the U.S. contraceptive market and 25% of contraceptive consumers, causing millions of unnecessary ‘periods’ along the way. So, why hasn’t birth control evolved beyond the pseudo-period?
This is your Washington Week Ahead for the week of March 1.
U.S. health advisers have endorsed a one-dose COVID-19 vaccine from Johnson & Johnson that's expected to provide an easier-to-use option to fight the pandemic.
Following the Senate Intelligence Committee hearing on the widespread SolarWinds cyberattack, cybersecurity experts are pushing the need for private businesses and federal agencies to cooperate closely to prevent future such breaches.
From Wall Street to Silicon Valley, these are the top stories that moved markets and had investors, business leaders, and entrepreneurs talking this week on Cheddar.
